Statin use and 30-day mortality in patients with acute symptomatic pulmonary embolism.

Carmine Siniscalchi Alfonso Muriel-Garcia Jose Maria Suriñach Caralt Behnood Bikdeli David Jiménez José Luis Lobo Cristina Amado Aída Gil-Díaz Egidio Imbalzano Manuel Monrealnull null

Published in: Journal of thrombosis and haemostasis : JTH (2022)

PE patients using statins at baseline had a significantly lower risk of dying within the first 30 days than non-users. Randomized trials are needed to confirm these data.

Keyphrases

pulmonary embolism
end stage renal disease
cardiovascular disease
ejection fraction
inferior vena cava
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
coronary artery disease
type diabetes
risk factors
electronic health record
machine learning
artificial intelligence
data analysis